Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?

Lancet Infect Dis. 2018 Aug;18(8):830-831. doi: 10.1016/S1473-3099(18)30346-3. Epub 2018 Jul 11.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Belgium
  • Heptavalent Pneumococcal Conjugate Vaccine / administration & dosage*
  • Humans
  • Immunization Programs / organization & administration
  • Immunization Programs / standards*
  • Infant
  • Infant, Newborn
  • Pneumococcal Infections / prevention & control*
  • Pneumococcal Vaccines / administration & dosage*
  • Streptococcus pneumoniae / isolation & purification
  • Vaccines, Conjugate

Substances

  • 10-valent pneumococcal conjugate vaccine
  • Heptavalent Pneumococcal Conjugate Vaccine
  • Pneumococcal Vaccines
  • Vaccines, Conjugate